Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nuris Ledon"'
Publikováno v:
VacciMonitor, Vol 26, Iss 2, Pp 44-53 (2017)
El crecimiento de las empresas en un mundo altamente competitivo depende del rendimiento superior del proceso de desarrollo de sus productos. Estudios anteriores mostraron que hoy la dificultad principal del crecimiento del Centro de Inmunología Mol
Externí odkaz:
https://doaj.org/article/b7ead8cfa558464ea58917fea9310582
Publikováno v:
VacciMonitor, Vol 26, Iss 1, Pp 31-43 (2017)
El crecimiento de las empresas en un mundo altamente competitivo depende del rendimiento superior del proceso de desarrollo de sus productos. En este artículo se sistematizan los elementos teóricos relacionados con la gestión de desarrollo de prod
Externí odkaz:
https://doaj.org/article/5706d2e69058414882fbdf1b31bc0124
Autor:
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Antonio Bencomo-Hernandez, Danay Saavedra
Publikováno v:
Exploration of Immunology, Vol 4, Iss 4, Pp 433-445 (2024)
Aim: Currently, malignant diseases represent a health issue worldwide. Among these, lung cancer is of growing importance, due to its high incidence and mortality. Chemotherapy, one of the most frequently used treatments, has shown its ability to indu
Externí odkaz:
https://doaj.org/article/0b6fbfbd307b4617a1722a3f7ca859ec
Publikováno v:
Journal of Pharmaceutical Sciences. 106:1475-1481
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98466adcdda6d7510828f8a775b266dd
https://doi.org/10.1016/j.xphs.2017.02.009
https://doi.org/10.1016/j.xphs.2017.02.009
Autor:
Danay Saavedra, Ana Laura Añé-Kourí, Nir Barzilai, Calogero Caruso, Kyung-Hyun Cho, Luigi Fontana, Claudio Franceschi, Daniela Frasca, Nuris Ledón, Laura J. Niedernhofer, Karla Pereira, Paul D. Robbins, Alexa Silva, Gisela M. Suarez, Wim Vanden Berghe, Thomas von Zglinicki, Graham Pawelec, Agustín Lage
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Aging is a gradual, continuous series of natural changes in biological, physiological, immunological, environmental, psychological, behavioral, and social processes. Aging entails changes in the immune system characterized by a decrease in t
Externí odkaz:
https://doaj.org/article/4c145aa2e8744ecfa51288f777b2ec7a
Publikováno v:
Journal of pharmaceutical sciences. 106(6)
This study examined the safety, pharmacodynamic and pharmacokinetic similarity of the human recombinant filgrastim products ior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::386ef330d3fa43d31915ba72e74a319a
https://pubmed.ncbi.nlm.nih.gov/28238900
https://pubmed.ncbi.nlm.nih.gov/28238900
Publikováno v:
Journal of pharmaceutical sciences. 103(11)
This study examined the safety, pharmacodynamic (PD), and pharmacokinetic (PK) biosimilarity of the human recombinant erythropoietin (EPO) products ior(®) EPOCIM and Eprex(®) following a 28-day repeated intravenous dose administration in male and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ef1ec33337fc3dc70edb1bd6c54eaf
https://pubmed.ncbi.nlm.nih.gov/25250536
https://pubmed.ncbi.nlm.nih.gov/25250536
Autor:
Ana Victoria Casadesús, Beatriz María Cruz, Wilden Díaz, Miguel Ángel González, Tania Gómez, Briandy Fernández, Addys González, Nuris Ledón, Katya Sosa, Kathleen Castro, Armando López, Claudia Plasencia, Yaima Ramírez, Jean-Luc Teillaud, Calixto Hernández, Kalet León, Tays Hernández
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionThe anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relapsing lymphomas. An approach to increase the clinical effecti
Externí odkaz:
https://doaj.org/article/27dd8b21477249bb9be6a6d8cabd48c2
Autor:
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Manuel Díaz, María de los A. Molina, Karla Pereira, Jenysbel de la C. Hernández, Raúl Ramos, Mary Carmen Reyes, Nuris Ledón, Zaima Mazorra, Tania Crombet, Agustin Lage, Danay Saavedra
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is the second cause of cancer related deaths worldwide. Chemotherapy and immunotherapy represent the current standard of care for advanced NSCLC. Platinum-based chemotherapy expands late-differentiated T cell populations. Therefore, immun
Externí odkaz:
https://doaj.org/article/4386dbb52c084a3f8acdfe664662a93a
Autor:
Arteaga, Maria Elene, Nuris Ledon, Nuris, Casaco, Angel, Pardo, Balia, Garcia, Miriam, Boleda, Magela, Vina, Lisel, Orphee, Romy, Hernandez, Osvaldo, Gonzalez, Consuelo, Fuentes, Dasha, Rodriguez, Valia, Charro, Lidia, Baro, Farah, Macias, Amparo, Perez, Aylen, Morales, Yakelin, Subiros, Nelvys, Gonzalez, Barbara, Ramos, Mayra, Rodriquez, Leyanis, Ballester-Labrada, Alcides, Crombet, Tania
Publikováno v:
Cancer Biology and Therapy; September 2007, Vol. 6 Issue: 9 p1386-1391, 6p